Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

NS Gray, L Wodicka, AMWH Thunnissen, TC Norman… - Science, 1998 - science.org
Selective protein kinase inhibitors were developed on the basis of the unexpected binding
mode of 2,6,9-trisubstituted purines to the adenosine triphosphate–binding site of the human …

[PDF][PDF] Synthesis and application of functionally diverse 2, 6, 9-trisubstituted purine libraries as CDK inhibitors

…, GR Rosania, DP Sutherlin, S Kwon, TC Norman… - Chemistry & biology, 1999 - cell.com
Background Purines constitute a structural class of protein ligands involved in mediating an
astonishing array of metabolic processes and signal pathways in all living organisms. …

[HTML][HTML] Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection

…, D Waggott, VY Sabelnykova, MR Kellen, TC Norman… - Nature …, 2015 - nature.com
The detection of somatic mutations from cancer genome sequences is key to understanding
the genetic basis of disease progression, patient survival and response to therapy. …

Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms

…, S Harrer, A Trister, S Friend, T Norman… - JAMA network …, 2020 - jamanetwork.com
Importance Mammography screening currently relies on subjective human interpretation.
Artificial intelligence (AI) advances could be used to increase mammography screening …

Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains

…, EM Driggers, DA Holtzman, TC Norman… - Nature …, 2003 - nature.com
We describe a method to decipher the complex inter-relationships between metabolite
production trends and gene expression events, and show how information gleaned from such …

[HTML][HTML] Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

…, ME Ahsen, R Vogel, EC Neto, T Norman… - Nature …, 2019 - nature.com
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …

Optimized clinical performance of growth hormone with an expanded genetic code

…, P Castiglioni, TC Norman… - Proceedings of the …, 2011 - National Acad Sciences
The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides
the opportunity to endow therapeutic proteins with unique pharmacological properties. …

[HTML][HTML] Inferring causal molecular networks: empirical assessment through a community-based effort

…, AJ Bisberg, GB Mills, JW Gray, M Kellen, T Norman… - Nature …, 2016 - nature.com
It remains unclear whether causal, rather than merely correlational, relationships in molecular
networks can be inferred in complex biological settings. Here we describe the HPN-…

FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents

…, AM Putnam, J Yao, S Bussell, M Wu, TC Norman… - Diabetes, 2012 - Am Diabetes Assoc
Fibroblast growth factor 21 (FGF21) mitigates many of the pathogenic features of type 2
diabetes, despite a short circulating half-life. PEGylation is a proven approach to prolonging the …

[HTML][HTML] CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation

…, SS Kerwar, R Lum, RL Mackman, TC Norman… - Journal of Biological …, 1997 - ASBMB
The activity of cyclin-dependent kinase 2 (CDK2) is essential for progression of cells from G
1 to the S phase of the mammalian cell cycle. CVT-313 is a potent CDK2 inhibitor, which was …